Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday announced a strategic partnership agreement with th...
The drugmaker will provide, at no profit, doses to treat up to 2 million people in resource-limited ...
Gilead Sciences's (NYSE:GILD) short percent of float has risen 10.12% since its last report. The com...
Lbp Am Sa trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.5% in the firs...